Cord cell treatment for severe systemic sclerosis symptoms
Part of Skin clinical trials.
This early-phase study tests whether umbilical cord-derived “cord blood–type” cells can reduce or improve severe systemic sclerosis (a type of hardening/scarring disease of connective tissue). It may help people whose current standard treatments haven’t worked or caused side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have systemic sclerosis confirmed by standard diagnostic criteria
- Your disease is considered severe, such as recent disease with lung or blood-related issues, or higher severity plus organ involvement
- You have tried standard medicine (often methotrexate and/or mycophenolate) for at least 3 months but it didn’t work or caused stopping due to side effects
- You are not eligible for, or do not want, an autologous stem cell transplant (your own stem cells)
- You must be willing and able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from umbilical cord blood can help treat systemic sclerosis (scleroderma). The goal is to see if this treatment can improve skin thickening and overall symptoms for people who haven't had success with standard therapies.
This trial tests whether infusing stem cells from donated fat tissue can help people with severe systemic sclerosis (an autoimmune disease causing skin thickening and organ damage). The goal is to reduce symptoms and slow disease progression.
This trial tests a new treatment using stem cells from umbilical cords to help people with scleroderma-related lung disease. It aims to see if the treatment can slow down or improve lung scarring and breathing problems.
This trial tests giving stem cells from a healthy donor to people with severe scleroderma that affects their lungs or heart. The goal is to see if these donor stem cells can calm the immune system and ease symptoms when standard treatments have stop working.
This early safety study tests whether an intravenous (through a vein) stem cell product made from donated umbilical cord cells is safe for people with systemic sclerosis. If you join, the goal is to see how your body tolerates the treatment and monitor for side effects.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
Hear when a new Mesenchymal Stem Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.